SPARC Nueron

Program Snapshot

The Common Fund’s Stimulating Peripheral Activity to Relieve Conditions (SPARC) program accelerates development of therapeutic devices that modulate electrical activity in nerves to improve organ function. This therapeutic strategy, also known as “bioelectronic medicine,” could offer new treatment options for diverse diseases and conditions such as hypertension, heart failure, gastrointestinal disorders, and more.

SPARC Awards: Other Transactions (OT2 and OT3) and Cooperative Agreements (U18 and U01)

Use the various organ and neuromodulation icons below to explore the SPARC research portfolio.

Please be aware that some projects span multiple organs and other neural targets.

This page last reviewed on May 2, 2022